| Management of patients with advanced prostate cancer: the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017 S Gillessen, G Attard, TM Beer, H Beltran, A Bossi, R Bristow, B Carver, ... European urology 73 (2), 178-211, 2018 | 531 | 2018 |
| Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx and larynx: a treatment planning comparison with fixed field IMRT E Vanetti, A Clivio, G Nicolini, A Fogliata, S Ghosh-Laskar, JP Agarwal, ... Radiotherapy and Oncology 92 (1), 111-117, 2009 | 433 | 2009 |
| Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis T Gupta, Z Master, S Kannan, JP Agarwal, S Ghsoh-Laskar, V Rangarajan, ... European journal of nuclear medicine and molecular imaging 38, 2083-2095, 2011 | 422 | 2011 |
| Management of patients with advanced prostate cancer: report of the advanced prostate cancer consensus conference 2019 S Gillessen, G Attard, TM Beer, H Beltran, A Bjartell, A Bossi, A Briganti, ... European urology 77 (4), 508-547, 2020 | 393 | 2020 |
| Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial T Gupta, JP Agarwal, S Jain, R Phurailatpam, S Kannan, S Ghosh-Laskar, ... Radiotherapy and Oncology 104 (3), 343-348, 2012 | 388 | 2012 |
| Once-a-week versus once-every-3-weeks cisplatin chemoradiation for locally advanced head and neck cancer: a phase III randomized noninferiority trial V Noronha, A Joshi, VM Patil, J Agarwal, S Ghosh-Laskar, A Budrukkar, ... Journal of Clinical Oncology 36 (11), 1064-1072, 2018 | 352 | 2018 |
| Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study EK Bancroft, EC Page, E Castro, H Lilja, A Vickers, D Sjoberg, M Assel, ... European urology 66 (3), 489-499, 2014 | 308 | 2014 |
| Prostate-only versus whole-pelvic radiation therapy in high-risk and very high-risk prostate cancer (POP-RT): outcomes from phase III randomized controlled trial V Murthy, P Maitre, S Kannan, G Panigrahi, R Krishnatry, G Bakshi, ... Journal of Clinical Oncology 39 (11), 1234-1242, 2021 | 281 | 2021 |
| Interim results from the IMPACT study: evidence for prostate-specific antigen screening in BRCA2 mutation carriers EC Page, EK Bancroft, MN Brook, M Assel, MH Al Battat, S Thomas, ... European urology 76 (6), 831-842, 2019 | 250 | 2019 |
| The Lancet Commission on prostate cancer: planning for the surge in cases ND James, I Tannock, J N'Dow, F Feng, S Gillessen, SA Ali, B Trujillo, ... The Lancet 403 (10437), 1683-1722, 2024 | 191 | 2024 |
| Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three … S Rathod, T Gupta, S Ghosh-Laskar, V Murthy, A Budrukkar, JP Agarwal Oral oncology 49 (6), 634-642, 2013 | 174 | 2013 |
| Hypofractionated, palliative radiotherapy for advanced head and neck cancer JP Agarwal, B Nemade, V Murthy, S Ghosh-Laskar, A Budrukkar, T Gupta, ... Radiotherapy and Oncology 89 (1), 51-56, 2008 | 138 | 2008 |
| Prospective randomized controlled trial to compare 3‐dimensional conformal radiotherapy to intensity‐modulated radiotherapy in head and neck squamous cell carcinoma: Long‐term … S Ghosh–Laskar, PH Yathiraj, D Dutta, V Rangarajan, N Purandare, ... Head & neck 38 (S1), E1481-E1487, 2016 | 125 | 2016 |
| A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer VM Patil, V Noronha, A Joshi, J Agarwal, S Ghosh‐Laskar, A Budrukkar, ... Cancer 125 (18), 3184-3197, 2019 | 122 | 2019 |
| Introduction of situation, background, assessment, recommendation into nursing practice: a prospective study MS Achrekar, V Murthy, S Kanan, R Shetty, M Nair, N Khattry Asia-Pacific journal of oncology nursing 3 (1), 45-50, 2016 | 120 | 2016 |
| A randomised phase 2 trial of dexamethasone versus prednisolone in castration-resistant prostate cancer R Venkitaraman, D Lorente, V Murthy, K Thomas, L Parker, R Ahiabor, ... European urology 67 (4), 673-679, 2015 | 106 | 2015 |
| Objective assessment of swallowing function after definitive concurrent (chemo) radiotherapy in patients with head and neck cancer J Agarwal, V Palwe, D Dutta, T Gupta, SG Laskar, A Budrukkar, V Murthy, ... Dysphagia 26, 399-406, 2011 | 101 | 2011 |
| Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: report of the Advanced Prostate Cancer Consensus Conference (APCCC … S Gillessen, A Bossi, ID Davis, J de Bono, K Fizazi, ND James, N Mottet, ... European journal of cancer 185, 178-215, 2023 | 99 | 2023 |
| ‘Plan of the day’adaptive radiotherapy for bladder cancer using helical tomotherapy V Murthy, Z Master, P Adurkar, I Mallick, U Mahantshetty, G Bakshi, ... Radiotherapy and Oncology 99 (1), 55-60, 2011 | 95 | 2011 |
| Management of patients with advanced prostate cancer: report from the Advanced Prostate Cancer Consensus Conference 2021 S Gillessen, A Armstrong, G Attard, TM Beer, H Beltran, A Bjartell, A Bossi, ... European urology 82 (1), 115-141, 2022 | 93 | 2022 |
